Haemonetics Corp
F:HAZ

Watchlist Manager
Haemonetics Corp Logo
Haemonetics Corp
F:HAZ
Watchlist
Price: 90.5 EUR -1.63% Market Closed
Market Cap: €4.6B

Wall St Price Targets

HAZ Price Forecast
Based on 13 analysts

-45% Downside
from €90.5 today

Haemonetics Corp (HAZ)’s 12-month stock price forecast through October 2027 has a consensus target of €49.98, implying 45% downside. The forecast is based on price targets from 13 Wall Street analysts.

HAZ Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for HAZ yet.

Haemonetics Corp Competitors:
Price Targets

Financial forecasts

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Value YoY Lowest–highest Analysts
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is HAZ's stock price target?
Price Target
49.98 EUR

According to Wall Street analysts, the average 1-year price target for HAZ is 49.98 EUR with a low forecast of 39.85 EUR and a high forecast of 54.51 EUR.

What is the Revenue forecast for Haemonetics Corp?
Projected CAGR
6%

Over the last 13 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 4 years is 6%.

What is the Gross Profit forecast for Haemonetics Corp?
Projected CAGR
7%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 5%. The projected CAGR for the next 4 years is 7%.

What is the Operating Income forecast for Haemonetics Corp?
Projected CAGR
18%

Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 4 years is 18%.

What is the Pre-Tax Income forecast for Haemonetics Corp?
Projected CAGR
47%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 8%. The projected CAGR for the next 3 years is 47%.

What is the Net Income forecast for Haemonetics Corp?
Projected CAGR
36%

Over the last 13 years, the compound annual growth rate for Net Income has been 7%. The projected CAGR for the next 4 years is 36%.

Back to Top